PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-3.47%
Negative net income growth while AVGO stands at 4.08%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
0.94%
Some D&A expansion while AVGO is negative at -11.28%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-30.43%
Negative yoy deferred tax while AVGO stands at 67.54%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
1.82%
SBC growth while AVGO is negative at -1.11%. John Neff would see competitor possibly controlling share issuance more tightly.
-316.27%
Both reduce yoy usage, with AVGO at -167.94%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-23.27%
Both yoy AR lines negative, with AVGO at -163.17%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-328.79%
Both reduce yoy inventory, with AVGO at -23.88%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
-31.73%
Negative yoy AP while AVGO is 119.13%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-115.15%
Both reduce yoy usage, with AVGO at -176.47%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-96.83%
Negative yoy while AVGO is 93.18%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-37.95%
Both yoy CFO lines are negative, with AVGO at -7.02%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-7.64%
Both yoy lines negative, with AVGO at -11.76%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-750.00%
Negative yoy acquisition while AVGO stands at 96.33%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-9533.33%
Negative yoy purchasing while AVGO stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-50.00%
We reduce yoy sales while AVGO is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-43200.00%
Both yoy lines negative, with AVGO at -500.00%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-598.68%
Both yoy lines negative, with AVGO at -22.00%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-152.27%
Both yoy lines negative, with AVGO at -21.62%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.